Vivacitas Oncology Competitors and Similar CompaniesClear all
Vivacitas Oncology's competitors and similar companies include Repertoire Immune Medicines, Beta Innov, Beactica and MiNK Therapeutics.
 Vivacitas Oncology Vivacitas Oncology is a company developing approaches for cancers resistant to standard treatment modalities. |  Repertoire Immune Medicines Repertoire Immune Medicines is a biotechnology company tapping the curative powers of the immune system to prevent, treat, or cure cancer, autoimmune conditions, and infectious diseases. |  MiNK Therapeutics MiNK Therapeutics (formerly AgenTus Biosciences, AgenTus Therapeutics) is a biopharmaceutical company that develops allogeneic iNKT cell therapies to treat cancer and immune-mediated diseases. | |||
Founding Date | Founding Date 2015 | Founding Date 2015 | Founding Date 2009 | Founding Date 2006 | Founding Date 2017 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Walnut Creek, US HQ | Locations Cambridge, US HQ Schlieren, CH Cambridge, US | Locations Paris, FR HQ | Locations Uppsala, SE HQ Uppsala, SE Uppsala, SE | Locations New York, US HQ Cambridge, GB |
Employees | Employees 6 | Employees 887% increase | Employees 14 | Employees 16 | Employees 34 |
For sources of this data, please see the company profile
View Company Profiles
Repertoire Immune Medicines
HQ
Cambridge, US
Employees
88↑ 7% increase
Repertoire Immune Medicines is a biotechnology company tapping the curative powers of the immune system to prevent, treat, or cure cancer, autoimmune conditions, and infectious diseases.
View company
Beta Innov
HQ
Paris, FR
Employees
14
Beta Innov is a pharmaceutical research and development company.
View company
Beactica
HQ
Uppsala, SE
Employees
16
Beactica is a company that specializes in fragment-based drug discovery.
View companyMiNK Therapeutics
HQ
New York, US
Employees
34
MiNK Therapeutics (formerly AgenTus Biosciences, AgenTus Therapeutics) is a biopharmaceutical company that develops allogeneic iNKT cell therapies to treat cancer and immune-mediated diseases.
View company